Mixed Neuroendocrine Non-Neuroendocrine Neoplasm of the Ampulla of Vater: Report of a Rare Location

REFERENCES

1. 1.↵
   1. Lewin K

   . Carcinoid tumors and the mixed (composite) glandular-endocrine cell carcinomas. Am J Surg Pathol. 1987;11 Suppl 1:71-86. doi: 10.1097/00000478-198700111-00007

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Lloyd RV,
   2. Osamura RY,
   3. Klöppel G,
   4. Rosai J

   , eds. WHO Classification of Tumours of Endocrine Organs: WHO Classification of Tumours. 4^th ed, vol 10. World Health Organization; 2017.
3. 3.↵
   1. Elpek GO

   . Mixed neuroendocrine-nonneuroendocrine neoplasms of the gastrointestinal system: an update. World J Gastroenterol. 2022;28(8):794-810. doi: 10.3748/wjg.v28.i8.794

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Xu B,
   2. Zhang F,
   3. Wu R,
   4. Peng Y,
   5. Mao Z,
   6. Tong S

   . Incidence, survival, and prognostic factors for patients with gastrointestinal mixed neuroendocrine non-neuroendocrine neoplasms: a SEER population-based study. J Cancer Res Clin Oncol. 2023;149(17):15657-15669. doi: 10.1007/s00432-023-05356-z

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Frizziero M,
   2. Chakrabarty B,
   3. Nagy B,
   4. et al.

   Mixed neuroendocrine non-neuroendocrine neoplasms: a systematic review of a controversial and underestimated diagnosis. J Clin Med. 2020;9(1):273. doi: 10.3390/jcm9010273

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Sung MK,
   2. Lee W,
   3. Hong S,
   4. et al.

   Mixed adenoneuroendocrine carcinoma of the ampulla of Vater: three case reports and a literature review. Ann Hepatobiliary Pancreat Surg. 2023;27(1):107-113. doi: 10.14701/ahbps.22-054

   OpenUrlCrossRefPubMed
7. 7.
   1. Meedimale S,
   2. Panda SS,
   3. Mohanty S,
   4. Mohanty SS,
   5. Biswas G

   . Ampullary mixed neuroendocrine non-neuroendocrine neoplasm (MiNEN) is an exceptionally rare case presenting as abdominal pain. J Cancer Res Ther. 2024;20(6):1930-1933. doi: 10.4103/jcrt.jcrt_183_23

   OpenUrlCrossRef
8. 8.
   1. Date K,
   2. Tatsuguchi T,
   3. Shimokawa Y,
   4. et al.

   Mixed neuroendocrine-non-neuroendocrine neoplasm of the ampulla of Vater: a case report. Surg Case Rep. 2023;9(1):102. doi: 10.1186/s40792-023-01689-6

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Tamaki A,
   2. Tani Y,
   3. Sato H,
   4. et al.

   Surgical resection of mixed neuroendocrine-non-neuroendocrine neoplasm in the biliary system: a report of two cases. Surg Case Rep. 2022;8(1):38. doi: 10.1186/s40792-022-01386-w

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Brierley JD,
    2. Gospodarowicz MK,
    3. Wittekind C

    , eds. TNM Classification of Malignant Tumours. 8th ed. Wiley-Blackwell; 2017.
11. 11.↵
    1. Nagtegaal ID,
    2. Odze RD,
    3. Klimstra D,
    4. et al.

    The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020;76(2):182-188. doi: 10.1111/his.13975

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Huang Z,
    2. Xiao WD,
    3. Li Y,
    4. Huang S,
    5. Cai J,
    6. Ao J

    . Mixed adenoneuroendocrine carcinoma of the ampulla: two case reports. World J Gastroenterol. 2015;21(7):2254-2259. doi: 10.3748/wjg.v21.i7.2254

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Zhong Y,
    2. Zhang H,
    3. Wang X,
    4. et al.

    CT and MR imaging features of mixed neuroendocrine-non-neuroendocrine neoplasm of the pancreas compared with pancreatic ductal adenocarcinoma and neuroendocrine tumor. Insights Imaging. 2023;14(1):15. doi: 10.1186/s13244-023-01366-0

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Rha SE,
    2. Jung SE,
    3. Lee KH,
    4. Ku YM,
    5. Byun JY,
    6. Lee JM

    . CT and MR imaging findings of endocrine tumor of the pancreas according to WHO classification. Eur J Radiol. 2007;62(3):371-377. doi: 10.1016/j.ejrad.2007.02.036

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Zheng M,
    2. Li T,
    3. Li Y,
    4. et al.

    Survival profile and prognostic factors for appendiceal mixed neuroendocrine non-neuroendocrine neoplasms: a SEER population-based study. Front Oncol. 2020;10:1660. doi: 10.3389/fonc.2020.01660

    OpenUrlCrossRefPubMed
16. 16.↵
    1. Toor D,
    2. Loree JM,
    3. Gao ZH,
    4. Wang G,
    5. Zhou C

    . Mixed neuroendocrine-non-neuroendocrine neoplasms of the digestive system: a mini-review. World J Gastroenterol. 2022;28(19):2076-2087. doi: 10.3748/wjg.v28.i19.2076

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Wang KL,
    2. Yang Q,
    3. Cleary KR,
    4. et al.

    The significance of neuroendocrine differentiation in adenocarcinoma of the esophagus and esophagogastric junction after preoperative chemoradiation. Cancer. 2006;107(7):1467-1474. doi: 10.1002/cncr.22179

    OpenUrlCrossRefPubMedWeb of Science
18. 18.↵
    1. La Rosa S,
    2. Marando A,
    3. Sessa F,
    4. Capella C

    . Mixed adenoneuroendocrine carcinomas (MANECs) of the gastrointestinal tract: an update. Cancers (Basel). 2012;4(1):11-30. doi: 10.3390/cancers4010011

    OpenUrlCrossRefPubMed
19. 19.↵
    1. Yoshimachi S,
    2. Ohtsuka H,
    3. Aoki T,
    4. et al.

    Mixed adenoneuroendocrine carcinoma of the ampulla of Vater: a case report and literature review. Clin J Gastroenterol. 2020;13(1):37-45. doi: 10.1007/s12328-019-01009-2

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Surjan RCT,
    2. Paulino JFA,
    3. Schleinstein HP,
    4. Pereira FMT,
    5. Figueira ERR,
    6. Ardengh JC

    . Robotic pancreaticoduodenectomy for the treatment of a mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN) of the ampulla of Vater. Arq Bras Cir Dig. 2024;37:e1840. doi: 10.1590/0102-6720202400046e1840

    OpenUrlCrossRefPubMed
21. 21.↵
    1. Cattaneo L,
    2. Centonze G,
    3. Sabella G,
    4. et al.

    Digestive MiNENs: could histological classification and molecular characterization drive clinical outcome and therapeutic approach? Crit Rev Oncol Hematol. 2023;188:104044. doi: 10.1016/j.critrevonc.2023.104044

    OpenUrlCrossRefPubMed
22. 22.
    1. Milione M,
    2. Maisonneuve P,
    3. Pellegrinelli A,
    4. et al.

    Ki67 proliferative index of the neuroendocrine component drives MANEC prognosis. Endocr Relat Cancer. 2018;25(5):583-593. doi: 10.1530/ERC-17-0557

    OpenUrlAbstract/FREE Full Text
23. 23.↵
    1. Centonze G,
    2. Maisonneuve P,
    3. Prinzi N,
    4. et al.

    Prognostic factors across poorly differentiated neuroendocrine neoplasms: a pooled analysis [published correction appears in Neuroendocrinology. 2024;114(6):602. doi: 10.1159/000538574]. Neuroendocrinology. 2023;113(4):457-469. doi: 10.1159/000528186

    OpenUrlCrossRefPubMed
24. 24.↵
    1. Pommergaard HC,
    2. Nielsen K,
    3. Sorbye H,
    4. et al.

    Surgery of the primary tumour in 201 patients with high-grade gastroenteropancreatic neuroendocrine and mixed neuroendocrine-non-neuroendocrine neoplasms. J Neuroendocrinol. 2021;33(5):e12967. doi: 10.1111/jne.12967

    OpenUrlCrossRefPubMed